UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant  ☒                            Filed by a party other than the Registrant  ☐

Check the appropriate box:

☐ Preliminary Proxy Statement

☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐ Definitive Proxy Statement

☒ Definitive Additional Materials

☐ Soliciting Material Pursuant to §240.14a-12

Frequency Therapeutics, Inc.

(Name of Registrant as Specified in its Charter)

Not applicable.

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

☒	No fee required.
☐	Fee paid previously with preliminary materials.
☐	Fee computed on table in exhibit required by Item 25 (b) per Exchange Act Rules 14a-6 (i) (1) and D-11.

  P.O. BOX 8016, CARY, NC 27512-9903 Frequency Therapeutics, Inc. Important Notice Regarding the Availability of Proxy Materials   Stockholders Meeting to be held on June 21, 2022 For Stockholders of record as of April 22, 2022   This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting.   To view the proxy materials, and to obtain directions to attend the meeting, go to: www.proxydocs.com/FREQ   To vote your proxy while visiting this site, you will need the 12 digit control number in the box below.   Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the internet.  

For a convenient way to view proxy materials and VOTE go to www.proxydocs.com/FREQ   Have the 12 digit control number located in the shaded box above available when you access the website and follow the instructions.  

If you want to receive a paper or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year’s meeting, you must make this request on or before June 10, 2022.

To order paper materials, use one of the following methods.

  INTERNET www.investorelections.com/FREQ   TELEPHONE (866) 648-8133   * E-MAIL paper@investorelections.com

When requesting via the Internet or telephone you will need the 12 digit control number located in the shaded box above. * If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located above) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mail requesting material.

Frequency Therapeutics, Inc.

Meeting Type: Annual Meeting of Stockholders
Date:	Tuesday, June 21, 2022
Time:	9:00 AM, Eastern Time
Place:	Annual Meeting to be held live via the Internet - please visit
	www.proxydocs.com/FREQ for more details.
TO ATTEND the Annual Meeting of Frequency Therapeutics, Inc., please visit www.proxydocs.com/FREQ for virtual meeting registration details. SEE REVERSE FOR FULL AGENDA

Frequency Therapeutics, Inc.

Annual Meeting of Stockholders

THE BOARD OF DIRECTORS RECOMMENDS A VOTE:

FOR ON PROPOSALS 1 AND 2

PROPOSAL

1. To elect two (2) class III directors, each to serve until the 2025 annual meeting of our stockholders.

1.01 Timothy J. Barberich

1.02 Robert S. Langer

2. To ratify, in a non-binding vote, the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.

NOTE: To transact such other business as may properly come before the Annual Meeting or any continuation, postponement or adjournment thereof.